Maintenance fees coming due
62 maintenance fees come due in the 12 months from Nov 19, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,035,041 | Process for Triphosphate Oligonucleotide Synthesis In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 11,679,158 | Biodegradable Lipids for the Delivery of Active Agents In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · Medium confidence | Alnylam Pharmaceuticals, Inc. | In force | Dec 20, 2026 | Jun 21, 2027 | Medium confidence | |
| US 9,061,063 | Biodegradable Lipids for the Delivery of Active Agents In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 9,062,310 | Compositions and Methods for Inhibiting Expression of Factor VII Gene In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 11,685,918 | PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Dec 27, 2026 | Jun 28, 2027 | High confidence | |
| US 9,068,184 | Compositions and Methods for Inhibition of Expression of Protein C (PROC) Genes In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| US 10,337,010 | ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF In force Fee due Jan 2, 2027 Lapses if unpaid Jul 2, 2027 · Medium confidence | Alnylam Pharmaceuticals, Inc. | In force | Jan 2, 2027 | Jul 2, 2027 | Medium confidence | |
| US 9,090,895 | Compositions and Methods for Inhibiting Expression of the Hamp Gene In force Fee due Jan 28, 2027 Lapses if unpaid Jul 28, 2027 · Medium confidence | Alnylam Pharmaceuticals, Inc. | In force | Jan 28, 2027 | Jul 28, 2027 | Medium confidence | |
| US 10,369,226 | Biodegradable Lipids for the Delivery of Active Agents In force Fee due Feb 6, 2027 Lapses if unpaid Aug 6, 2027 · High confidence | Alnylam Pharmaceuticals, Inc. | In force | Feb 6, 2027 | Aug 6, 2027 | High confidence | |
| US 10,370,666 | Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof In force Fee due Feb 6, 2027 Lapses if unpaid Aug 6, 2027 · Medium confidence | Alnylam Pharmaceuticals, Inc. | In force | Feb 6, 2027 | Aug 6, 2027 | Medium confidence | |
| 52 more maintenance fees coming due in the 12 months from Nov 19, 2026 · Pro | |||||||
10 of 62 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.